Another competitor for the Ultimate Fighting Championship (UFC) is now facing a lenghty suspension for a failed drug test. This time around, UFC light heavyweight Michal Oleksiejczuk will be facing a year long suspension from the octagon.
Michal Oleksiejczuk failed a drug test within relationship to his unanimous decision victory over Khalil Rountree at UFC 219. The Nevada Athletic Commission (NAC) has since fined Oleksiejczuk a one-year suspension for the drug test failure. The fighter’s victory over Rountree has also been overturned to a no contest.
The fighter failed an in-competition drug test for the anti-estrogen agent clomiphene, leading to the lengthy suspension. Oleksiejczuk will also face a $3,600 and is required to provide a clean drug test before applying for relicensure.
Oleksiejczuk is not the only fighter to fail a drug test for the substance. Former UFC champions Jon Jones and Brock Lesnar each failed drug tests for clomiphene.
The United States Anti-Doping Agency (USADA) has yet to provide a ruling on the case of Oleksiejczuk’s drug test failure. Consequently, the fighter may face an even longer suspension once USADA has reached a verdict.
The fighter’s one year suspension will end Dec. 30, 2018.